Computer algorithms to characterize individual subject EMG profiles during gait

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Computer-Algorithmen zur Charakterisierung der individuellen EMG-Profile waehrend des Gehens
Autor:Bogey, Ross A.; Barnes, Lee A.; Perry, Jaquelin
Erschienen in:Archives of physical medicine and rehabilitation
Veröffentlicht:73 (1992), 9, S. 835-841, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource
Sprache:Englisch
ISSN:0003-9993, 1532-821X
Schlagworte:
Online Zugang:
Erfassungsnummer:PU199405062640
Quelle:BISp

Abstract

Three methods of precisely determining onset and cessation times of gait EMG were investigated. Subjects were 24 normal adults and 32 individuals with gait pathologies. Soleus muscle EMG during free speed level walking was obtained with fine wires, and was normalized by manual muscle test (MMT). Linear envelopes were generated from the rectified, integrated EMG at each percent gait cycle (GC) of each stride in individual gait trials. Three methods were used to generate EMG profiles for each tested subject. The ensemble average (EAV) was determined for each subject from the mean relative intensity of the linear envelopes. Low relative intensity or short duration EMG was removed from the ensemble average to create the intensity filtered average (IFA). The packet analysis method (PAC) created an EMG profile from the linear envelopes in successive strides whose respective centroid GC locations were within +/- 15GC of each other. Control values for onset and cessation times of individual gait trials were calculated after spurious outliers were removed. Mean onset and cessation times across subjects for control values and the experimental methods (EAV, IFA, and PAC) were calculated. Dunnetts test was performed to compare control and experimental groups in patient and normal trials. EAV differed from control values for onsets, cessations and durations in both normal and patient trials. IFA and PAC had no significant differences from control value means. IFA was selected for clinical use. Verf.-Referat (gekuerzt)